Background: Open heart surgery using cardiopulmonary bypass (CPB) is considered one of the most frequent surgical procedures in which acute kidney injury (AKI) is a frequent and serious complication. The aim of the present study was to evaluate the efficiency of neutrophil gelatinase-associated lipocalin (NGAL) as an early AKI biomarker after CPB in cardiac surgery (CS). Methods: Thirty-seven adult patients undergoing CS with CPB were included in this retrospective study. They had normal preoperative renal function, as assessed by the creatinine (Cr) level, NGAL level, and estimated glomerular filtration rate. Serial evaluation of serum NGAL and Cr levels was performed before, immediately after, and 24 hours after the operation. Patients were divided into two groups: those who showed normal immediate postoperative serum NGAL levels (group A, n=30) and those who showed elevated immediate postoperative serum NGAL levels (group B, n=7). Statistical analysis was performed using Statistical Package for the Social Sciences version 18. Results: Of the 37 patients, 6 (6/37, 16.2%) were diagnosed with AKI. One patient belonged to group A (1/30, 3.3%), and 5 patients belonged to group B (5/7, 71.4%). Two patients in group B (2/7, 28.5%) required further renal replacement therapy. Death occurred in only 1 patient (1/37, 2.7%), who belonged to group B. Conclusion: The results of this study suggest that postoperative plasma NGAL levels can be used as an early biomarker for the detection of AKI following CS using CPB. Further studies with a larger sample size are needed to confirm our results.
INTRODUCTION
Acute kidney injury (AKI) is a common complication of cardiac surgery, particularly when using the cardiopulmonary bypass (CPB) system. AKI after open heart surgery is known to be associated with increased postoperative mortality, morbidity, and in-hospital costs; reduced postoperative survival rate; and adverse patient outcomes [1] . Many attempts to reduce the development of AKI have been made, and several biomarkers, including serum creatinine (Cr) level, have been Plasma NGAL in AKI after CPB − 241 − Values are presented as mean±standard deviation or number (%).
used to detect AKI. Serum Cr levels have been used as the standard indicator of renal failure for several decades, but they have several limitations, such as low sensitivity for early detection of AKI. Even in patients with more than 50% damage to the kidney, serum Cr levels can be within the normal range. Hence, more elaborate and delicate detectors for cardiac surgery-associated (CSA) AKI are needed, and several reports have shown that neutrophil gelatinase-associated lipocalin (NGAL) might be an early and novel biomarker for the detection of CSA-AKI [2] . The aim of this study was to investigate whether increased serum NGAL levels could be a predictive biomarker of CSA-AKI. Venous whole blood samples with ethylenediaminetetraacetic acid, an anticoagulant, were collected and were analyzed within 1 hour after sample collection.
METHODS

1) Patients
3) Definition of acute kidney injury
On the basis of the definition of the Acute Kidney Injury (Table 1) . Further information regarding NGAL, Cr levels, and AKI is presented in Table 2 .
The preoperative serum NGAL levels of groups A and B were 65.51±20.84 and 76.28±26.10, respectively, the preoperative serum Cr levels of groups A and B were 0.82±0.13
and 0.95±0.83, respectively, and the preoperative serum eGFR levels of groups A and B were 98.83±16.16 and 92.79±14.25, respectively. There were no statistically significant differences in preoperative serum NGAL and Cr levels between the two groups (Table 2) . However, the immedi- Postoperative NGAL levels on ICU arrival and 24-hour post- Stage (RIFLE) criteria [3, 5] . AKI represents a significant problem in clinical medicine, with devastating immediate and long-term consequences [6, 7] . The incidence of AKI varies from 5% of hospitalized patients to 30% of patients at ICUs.
AKI is a frequent and serious complication in about 30% to 50% of patients undergoing cardiac surgery under CPB performed worldwide [8] . AKI requiring dialysis accounts for up to 5% of all cases, in which the mortality rate reaches 80% [9] . Diagnosis and management of AKI constitutes one of the most important roles of the cardiac surgeon after open heart surgery [10] . Recently, the standardized clinical definition of AKI has been implemented through the validation of the RIFLE and AKIN criteria [3, 5] . This standardized clinical definition using RIFLE and AKIN criteria has shown that irrespective of severity or stage, the true incidence of CSA-AKI is associated with prolonged treatment at the ICU, prolonged hospital stay, increased hospitalization cost, and increased patient morbidity/mortality [11] .
Many studies have reported that cardiac surgery under CPB is closely associated with postoperative renal injury. Fischer et al. [12] reported that AKI after CPB occurs in about 8%
of adult cardiac surgical patients with some preoperative renal However, CPB alone may also lead to AKI in which the glomerular filtration rate is decreased by 30% during CPB [15] .
In addition to hypothermia, vasoconstriction, and exposure to the microemboli generated by the activated cascades, struc- NGAL is a protein of the lipocalin family that is highly expressed in various pathologic states and is an early biomarker of AKI in various situations, such as cardiac surgery.
Compared with serum Cr, NGAL allows for earlier identification of patients with AKI. Previous studies have demonstrated that urine and plasma NGAL levels reach their peak within 6 hours after adult cardiac surgery, which predicts the development of AKI during an early postoperative period.
Additionally, these biomarkers are associated with a longer hospitalization and ICU stay and higher risk of dialysis or in-hospital death. A previous study has described the role of these biomarkers in a Cr-based AKI diagnosis [21] .
NGAL is a 25,000-dalton protein belonging to the lipocalin superfamily, which is composed of 8 beta-strands that form a beta-barrel enclosing a calyx that binds and transports low molecular weight chemicals [22] . In humans, NGAL is expressed by neutrophils and various epithelial cells and is commonly found in human organs, including the uterus, prostate, salivary gland, lung, trachea, stomach, colon, and kidney [23] . NGAL is generally expressed at very low concentrations in several human tissues and greatly elevated in patients with epithelial damage [24, 25] . In healthy kidneys, it is barely detectable in either plasma or urine. However, in the setting of acute tubular injury, NGAL undergoes rapid and profound up-regulation with significant increases in both urine and plasma [11] . Numerous studies have recently shown that NGAL binds to siderophores (iron-chelating molecules secreted by micro-organisms) and is highly expressed in various pathological states, particularly AKI. Several studies have suggested that NGAL is detected in first-stream urine and serum samples within 2 hours after ischemia and that the NGAL level correlates with the duration of renal ischemia [26] . The first clinical application of NGAL was the detection of inflammation and sepsis as a biomarker. Bacterial infection activates neutrophil secondary granules, which secrete NGAL into the blood stream. However, although NGAL is frequently detected in renal disease and neoplastic conditions, it has limited clinical use and low sensitivity as a biomarker for infection. For these reasons, sensitivity to infection is lower in NGAL than in C-reactive protein, and thus, NGAL has not been used in clinical practice [27, 28] . Further studies have demonstrated that NGAL is one of the earliest and most robustly induced proteins following renal ischemia and nephrotoxic insults. NGAL can be measured in both plasma and urine samples, and both serum and urinary NGAL levels have been found to be reliable predictors of AKI in patients undergoing cardiac surgery. NGAL measurements are probably more reflective of local renal injury because they are noninvasive and relatively free of interfering proteins [29] . Kuwabara et al. [32] reported that after kidney injury, the primary source of urinary NGAL was the glomerular filtrate, and this is caused by the proximal tubule damage. Both plasma and urine NGALs are increased after a renal injury, and even though the kidney is considered the major source of elevated plasma lipocalin, there are other plausible explanations.
Several studies using human and animal models have demon- to 550 ng/mL. Hence, there is no clear spectrum to offer the pertinent application of NGAL in AKI [36, 37] . Therefore, a definite range for the application of both urine and plasma in CSA-AKI should be clarified, and the relationship between both urine and plasma should be established.
An elevated level of serum NGAL is associated with CSA-AKI. This biomarker shows a relatively high sensitivity and specificity in patients with CSA-AKI and provides rapid results (within 15 minutes). These results enable us to detect and manage a patient with AKI early, avoiding unnecessary administration of nephrotoxic materials, such as contrast media and antibiotics.
In conclusion, the results of this study suggest that NGAL may be an early biomarker for CSA-AKI and thus, provide a basis for early interventional strategies for the prevention of CSA-AKI. Further studies with a larger sample size and a prospective design are needed to confirm our results.
